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In his commentary to the paper: "Calculation
of physical correction factors based on the L - Q
model", Prof. Ram Das pointed out the
differences between the mathematical formulas
to calculate ERD, presented by Barendsen
(1982) and Dale (1985).
According to Dale's correction, the biological
equivalence of the traditional Manchester
method and the Selectron LDR (dose rate 1,67
Gy/h) for the early and late tissue damage,
would require the reduction of the physical dose
by 28,5% and 48% respectively (table 1 and 2).
However, we should not forget, that the
radiobiological processes are not described by
precisely defined parameters. For example, sub
- lethal damage takes place in range of 30
minutes to several hours. Redistribution - in fast
proliferating tissues - a few days; repopulation -
several weeks; reoxygenation - probably a few
days (Steel 1993). Similarly, the alP values are
usually presented in a relatively wide range. For
this reason, we would like to point out, that the
results of the mathematical models calculations
have to be always referred to one's own and
other authors' clinical experience.
Comparing the Selectron LDR (dose rate 1,67
Gy/h) with the traditional Manchester technique,
our calculations indicate that the physical dose
should be reduced by 17%, assuming the
equivalence of ERD values for the early reaction
due to radiation damage (being aware of the
consequences of this, on the late responding
tissues and on the tumor). This is consistent e.g.
with the experience in the Christie Hospital in
Manchester, where Stout and Hunter
demonstrated in their trials (1983 - 88) exactly
the same value Le. 17%. In several other
publications, for dose - rate in the range of 1,5 -
1,8 Gy/h, a reduction of the physical dose by 10-
20% was considered necessary. Our own
experience based on over 3000 intracavitary
applications, also confirms the justness of the
assumption.
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The next point taken into consideration by
Prof. Ram Das, was the rectal dose. According
to our opinion, there do not exist any truly
comparable methods of calculation or
measurement of the dose in the rectum. For this
reason, big differences between the rectal dose
values quoted by different authors, occur.
Our definition of a choosen point at 0,5 cm
from the posterior surface of the ovoids, has
been adopted exclusively to determine the
dependence of the dose on the position of the
sources in the ovoids, and on the distance
between them. In clinical practice, we put a
Foley's catheter containing 5 ml of contrast in
the rectum, and with the help of the simulator we
place it under the ovoids. 3 or 4 reference points
are then determined on it's anterior surface.
Unfortunately this method is as good - or as
bad - as any other. The dosimetry in vivo is not
fully reliable either, because with the usage a
rigid or a flexible semiconductor detectors, we
would obtain significantly different results.
With big interest we read the last part of Prof.
Ram Das' commentary concerning his own
experience with introducing the Selectron LDR. In
our opinion, placing only one source in the ovoids
and 3 or 4 in the intrauterine tube, causes the
necessity of using the times of irradiation of over
30 h, when applying typical doses to point A.
Undoubtedly, this fact is associated with a big
discomfort for the patients, and at the same time,
has little clinical benefit, in our opinion.
In order to optimize the dose distribution in
point A, bladder and rectum, we would rather
stress the importance of a suitable application
technique, the adjustment of the type of
applicators to individual anatomical conditions of
each patient, an appropriate - adjusted to the
extent of the disease - configuration of the
sources in the applicators, as well as different
participation of intracavitary and external
irradiation, and the possibility of applying the
central shielding in external beam therapy.
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The optimization of the combined irradiation of
the cervical cancer, is the subject of
considerations enclosed in the paper actually
prepared.
Last remark. Elaborating new treatment
schedules, that differ in applicated dose - rate
values or dose per fraction, requires an arbitrary
choise of a mathematical formula and the values
of not always precisely defined radiobiological
parameters. Therefore, it is very important to
present one's own results in a way, which
enables their comparison with the parameters
assumed by other authors. For this reason we
thank Prof. Ram Das for his valuable remarks,
which will be taken into account in the actually
prepared paper.
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